Skip to content

Drug interactions

Lansoprazole + Tecovirimat

Severity: Minor

Lansoprazole and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat weakly inhibits CYP2C19 and weakly induces CYP3A4, both of which contribute to lansoprazole metabolism. The effects are likely to partly offset each other and to be small.

What this interaction means in plain words

Lansoprazole and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lansoprazole belongs to Gastrointestinal Tract; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Tecovirimat weakly inhibits CYP2C19 and weakly induces CYP3A4, which can alter lansoprazole clearance slightly in either direction.

What to do

No empirical dose adjustment is needed. Watch for reduced acid control or increased adverse effects of lansoprazole during a tecovirimat course.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lansoprazole and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lansoprazole with Tecovirimat?

MediHelp rates the interaction as minor. Lansoprazole and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat weakly inhibits CYP2C19 and weakly induces CYP3A4, both of which contribute to lansoprazole metabolism. The effects are likely to partly offset each other and to be small.

How serious is the interaction between Lansoprazole and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose adjustment is needed. Watch for reduced acid control or increased adverse effects of lansoprazole during a tecovirimat course.

What other medicines interact with Lansoprazole?

MediHelp also lists interactions of Lansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Lansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in